Liu F, Pinz K, Ma Y, et al. First-in-human CLL1-DC33 compound CAR T cells as a two-pronged approach for the treatment of refractory acute myeloid leukemia. EHA 2018; abstract S149.
2 recente lymfoomstudies niet opzienbarend, wel leerzaam
feb 2024 | Lymfoom